Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Credentis
company
About
Credentis develops and commercializes an enamel and dentin demineralization system to treat caries lesions and related illnesses.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- Fr1.59M
- Industries
- Biotechnology,Dental,Medical,Medical Device
- Founded date
- Jan 1, 2010
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Credentis is a Swiss company that develops and commercializes an enamel and dentin demineralization system for the treatment of caries lesions and related illnesses. It aims to provide dentists with a tool in tooth demineralization and help patients protect and regenerate their teeth.The company’s products include Curodont Repair, Curodont Protect, and Curodont D’Senz.Credentis was founded in 2010 and is based in Windisch, Aargau.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
Fr1.59M
Credentis has raised a total of
Fr1.59M
in funding over 2 rounds. Their latest funding was raised on
Mar 11, 2013 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 11, 2013 | Series B | Fr1.59M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Credentis is funded by 1 investors.
BioValley Business Angels Club (BioBAC)
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
BioValley Business Angels Club (BioBAC)
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
